skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 19 of 115  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: Neurology remove Database: SWEPUB Freely available online remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical risk factors in SUDEP: A nationwide population-based case-control study
Clinical risk factors in SUDEP: A nationwide population-based case-control study
Material Type:
Article 		Add to My Research

Clinical risk factors in SUDEP: A nationwide population-based case-control study

Neurology, 2020-01, Vol.94 (4), p.e419-e429 [Peer Reviewed Journal]

2020 American Academy of Neurology ;Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2019 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000008741 ;PMID: 31831600

Full text available

Citations Cited by
2
Vagotomy and Parkinson disease: A Swedish register–based matched-cohort study
Vagotomy and Parkinson disease: A Swedish register–based matched-cohort study
Material Type:
Article 		Add to My Research

Vagotomy and Parkinson disease: A Swedish register–based matched-cohort study

Neurology, 2017-05, Vol.88 (21), p.1996-2002 [Peer Reviewed Journal]

2017 American Academy of Neurology ;Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2017 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000003961 ;PMID: 28446653

Full text available

Citations Cited by
3
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
Material Type:
Article 		Add to My Research

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder

Neurology, 2017-03, Vol.88 (10), p.930-937 [Peer Reviewed Journal]

2017 American Academy of Neurology ;Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology 2017 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000003680 ;PMID: 28179466

Full text available

Citations Cited by
4
Plasma tau in Alzheimer disease
Plasma tau in Alzheimer disease
Material Type:
Article 		Add to My Research

Plasma tau in Alzheimer disease

Neurology, 2016-10, Vol.87 (17), p.1827-1835 [Peer Reviewed Journal]

2016 American Academy of Neurology ;2016 American Academy of Neurology. ;2016 American Academy of Neurology 2016 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000003246 ;PMID: 27694257

Full text available

Citations Cited by
5
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Material Type:
Article 		Add to My Research

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

Neurology, 2021-11, Vol.97 (19), p.e1870-e1885 [Peer Reviewed Journal]

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2021 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000012753 ;PMID: 34610987

Full text available

Citations Cited by
6
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
Material Type:
Article 		Add to My Research

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

Neurology, 2019-06, Vol.92 (23), p.e2661-e2673 [Peer Reviewed Journal]

2019 American Academy of Neurology ;2019 American Academy of Neurology. ;2019 American Academy of Neurology 2019 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000007600 ;PMID: 31118245

Full text available

Citations Cited by
7
National randomized controlled trial of virtual house calls for Parkinson disease
National randomized controlled trial of virtual house calls for Parkinson disease
Material Type:
Article 		Add to My Research

National randomized controlled trial of virtual house calls for Parkinson disease

Neurology, 2017-09, Vol.89 (11), p.1152-1161 [Peer Reviewed Journal]

2017 American Academy of Neurology. ;2017 American Academy of Neurology 2017 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000004357 ;PMID: 28814455

Full text available

Citations Cited by
8
ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project
ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project
Material Type:
Article 		Add to My Research

ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project

Neurology, 2020-07, Vol.95 (1), p.e46-e58 [Peer Reviewed Journal]

2020 American Academy of Neurology ;Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2020 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000009724 ;PMID: 32522798

Full text available

Citations Cited by
9
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Material Type:
Article 		Add to My Research

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

Neurology, 2017-11, Vol.89 (22), p.2230-2237 [Peer Reviewed Journal]

Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2017 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/wnl.0000000000004683 ;PMID: 29079686

Full text available

Citations Cited by
10
Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
Material Type:
Article 		Add to My Research

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study

Neurology, 2019-12, Vol.93 (24), p.e2216-e2223 [Peer Reviewed Journal]

2019 American Academy of Neurology ;Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2019 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000008617 ;PMID: 31704791

Full text available

Citations Cited by
11
Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy
Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy
Material Type:
Article 		Add to My Research

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy

Neurology, 2016-11, Vol.87 (20), p.2074-2081 [Peer Reviewed Journal]

2016 American Academy of Neurology ;2016 American Academy of Neurology. ;2016 American Academy of Neurology 2016 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000003331 ;PMID: 27760868

Full text available

Citations Cited by
12
Spatial-Temporal Patterns of β-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis
Spatial-Temporal Patterns of β-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis
Material Type:
Article 		Add to My Research

Spatial-Temporal Patterns of β-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis

Neurology, 2022-04, Vol.98 (17), p.e1692-e1703 [Peer Reviewed Journal]

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2022 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000200148 ;PMID: 35292558

Full text available

Citations Cited by
13
Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
Material Type:
Article 		Add to My Research

Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality

Neurology, 2021-04, Vol.96 (17), p.e2220-e2230 [Peer Reviewed Journal]

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2021 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/wnl.0000000000011832 ;PMID: 33741639

Full text available

Citations Cited by
14
Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease
Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease
Material Type:
Article 		Add to My Research

Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease

Neurology, 2021-03, Vol.96 (9), p.e1369-e1382 [Peer Reviewed Journal]

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2021 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/wnl.0000000000011528 ;PMID: 33495376

Full text available

Citations Cited by
15
Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain
Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain
Material Type:
Article 		Add to My Research

Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain

Neurology, 2019-02, Vol.92 (7), p.e700-e709 [Peer Reviewed Journal]

2019 American Academy of Neurology ;Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2019 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000006919 ;PMID: 30651382

Full text available

Citations Cited by
16
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
Material Type:
Article 		Add to My Research

Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease

Neurology, 2019-02, Vol.92 (6), p.e601-e612 [Peer Reviewed Journal]

2019 American Academy of Neurology ;Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2019 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000006875 ;PMID: 30626656

Full text available

Citations Cited by
17
FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders
FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders
Material Type:
Article 		Add to My Research

FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders

Neurology, 2016-11, Vol.87 (22), p.2290-2299 [Peer Reviewed Journal]

2016 American Academy of Neurology ;2016 American Academy of Neurology. ;Distributed under a Creative Commons Attribution 4.0 International License ;2016 American Academy of Neurology 2016 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000003374 ;PMID: 27794108

Full text available

Citations Cited by
18
NfL as a biomarker for neurodegeneration and survival in Parkinson disease
NfL as a biomarker for neurodegeneration and survival in Parkinson disease
Material Type:
Article 		Add to My Research

NfL as a biomarker for neurodegeneration and survival in Parkinson disease

Neurology, 2020-08, Vol.95 (7), p.e827-e838 [Peer Reviewed Journal]

2020 American Academy of Neurology ;Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000010084 ;PMID: 32680941

Full text available

Citations Cited by
19
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
Material Type:
Article 		Add to My Research

Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration

Neurology, 2021-05, Vol.96 (18), p.e2296-e2312 [Peer Reviewed Journal]

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2021 American Academy of Neurology ;ISSN: 0028-3878 ;ISSN: 1526-632X ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000011848 ;PMID: 33827960

Full text available

Citations Cited by

Results 1 - 19 of 115  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2010  (5)
  2. 2010 To 2012  (7)
  3. 2013 To 2015  (15)
  4. 2016 To 2019  (49)
  5. After 2019  (41)
  6. More options open sub menu

Language 

  1. Japanese  (14)
  2. Norwegian  (1)
  3. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait